RK-251 Cancer Drug Shows Promise
RK-251 Cancer Drug is a new ROS-activated compound from Indian researchers showing promise in early cancer studies.
Epstein-Barr Vaccine Advances Show Promising Progress in New Research
Epstein-Barr Vaccine Advances show promising antibody research that may prevent EBV infections, mononucleosis, cancers, and complications.
Cancer Reprogrammes Immunity: Study Reveals How Tumours Turn Defenders into Allies
Cancer Reprogrammes Immunity as tumours alter neutrophils to boost growth, reveals new study on CCL3 and cancer progression.
Cancer Mutation Treatment Target: Turning Drug Resistance into a New Hope for Cancer Care
Cancer Mutation Treatment Target research reveals how drug-resistant cancer mutations can be turned into powerful immunotherapy targets, offering new hope for advanced cancers.
Advanced Proton Therapy for Cancer Treatment: A New Era in Precision Oncology
Advanced Proton Therapy for Cancer Treatment offers precise tumor targeting with fewer side effects, improving outcomes and quality of life for patients.